Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation

BACKGROUND: Intravitreal anti-vascular endothelial growth factor (IVA) injection is known to cause contraction of fibrovascular proliferation (FVP), when present in severe retinopathy of prematurity (ROP). AIM: To assess the structural outcomes of IVA injection in the treatment of severe posterior R...

Descripción completa

Detalles Bibliográficos
Autores principales: Maitra, Puja, Prema, Subramaniam, Narendran, Venkatapathy, Shah, Parag K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518743/
https://www.ncbi.nlm.nih.gov/pubmed/37753496
http://dx.doi.org/10.5409/wjcp.v12.i4.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518743/
https://www.ncbi.nlm.nih.gov/pubmed/37753496
http://dx.doi.org/10.5409/wjcp.v12.i4.220

Ejemplares similares